Investment company Lvm Capital Management Ltd (Current Portfolio) buys Medtronic PLC, Zoetis Inc, Eaton Corp PLC, Norfolk Southern Corp, Qualcomm Inc, sells AT&T Inc, Activision Blizzard Inc, SPDR ...

Provides clinical development services, including early and late-phase trials, patient recruitment, medical imaging, laboratory services, and regulatory consulting, primarily for the pharmaceutical, ...

The deal represents a 0.33% change in 13F reportable assets under management. LVM's post-trade position is 39,485 shares valued at $19.74 million. NOC shares now account for 2.05% of the fund’s U.S.

Stock price: $147.59 as of July 8, 2025; one-year change: (54%); underperformed S&P 500 by 65.9 percentage points over the past year. No dividend; forward P/E ratio is 11.1; EV/EBITDA (LTM) is 10.1.